CLINICAL_TRIALS
trial_result
· 2024-01-29
Clinical Trial Update: A Study of Mirikizumab in Participants With Plaque Psoriasis [Phase 1]
Summary
A Phase 1 clinical trial of mirikizumab in participants with plaque psoriasis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2024-01-29